Literature DB >> 6113484

Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor.

J F Jones, L L Minnich, W S Jeter, R F Pritchett, V A Fulginiti, R J Wedgwood.   

Abstract

An illness lasting for two years, with recurrent fever, rash, abdominal pain, and arthralgia, developed in a four year old boy. He was found to have a combined Epstein-Barr virus and cytomegalovirus (CMV) infection. His symptoms, CMV in his urine, and an absent in vitro lymphocyte response to CMV antigen persisted for two years. After treatment with orally administered bovine transfer factor clinical symptoms and viruria disappeared and specific immunity to CMV developed. Evaluation of this treatment in chronic virus infections is warranted.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113484     DOI: 10.1016/s0140-6736(81)90301-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  1 in total

1.  Characterization and Safety Profile of Transfer Factors Peptides, a Nutritional Supplement for Immune System Regulation.

Authors:  Hudson Polonini; Any Elisa de Souza Schmidt Gonçalves; Eli Dijkers; Anderson de Oliveira Ferreira
Journal:  Biomolecules       Date:  2021-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.